Heinzerling, Keith G. http://orcid.org/0000-0001-9746-5821
Briones, Marisa
Thames, April D.
Hinkin, Charles H.
Zhu, Tianle
Wu, Ying Nian
Shoptaw, Steven J.
Funding for this research was provided by:
National Institute on Drug Abuse (DA035054)
Article History
Received: 28 June 2019
Accepted: 27 September 2019
First Online: 9 December 2019
Compliance with Ethical Standards
:
: Dr. Heinzerling has received study medication from MediciNova and DeNovo, has been a scientific advisor for Alkermes and Indivior, and is a founder of BDH Pharma, LLC. Dr. Briones is a founder of BDH Pharma, LLC. Dr. Shoptaw has received study medication from Gilead. No other authors declare potential conflicts.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.